T-cells Expressing an Anti-SLAMF7 CAR for Treating Multiple Myeloma
Clinical trial NCT03958656 · COMPLETED
Trial details
- NCT number
- NCT03958656
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-13
- Primary completion
- 2020-10-13
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.